We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





MedTest Dx Releases New Product Line for Drugs of Abuse Testing

By LabMedica International staff writers
Posted on 06 Aug 2019
Print article
Image: The MedTest Dx Clinitox Solution (Photo courtesy of MedTest Dx).
Image: The MedTest Dx Clinitox Solution (Photo courtesy of MedTest Dx).
MedTest Dx, Inc. (Canton, MI, USA) introduced an improved line of Clinitox Calibrators and Controls for confirmation testing at the 2019 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting. The company’s new product line provides laboratories performing confirmation testing a comprehensive, reliable, easy-to-use and customizable calibration and controls solution designed for accuracy and efficiency, with extended shelf life and simplified documentation. At AACC 2019, MedTest also launched a new Certified Performance Guarantee Program for its Pointe Scientific branded line of clinical chemistry diagnostic reagents.

MedTest, which offers integrated products and services for clinical diagnostic testing, has a combination of screening instruments, reagent manufacturing, service capabilities and full LC/MS toxicology confirmation products. The MedTest Dx Clinitox Solution is a comprehensive key system enabling labs to bring drugs of abuse confirmation testing in-house by increasing the ease and efficiency of confirmation testing, while reducing the cost. It provides streamlined sample preparation; rapid implementation; Certificates of Analysis; documentation for traceability, including routine or specialty compound cut-offs; multiple panel options; and custom LC/MS calibrators, controls and internal standards.

Clinitox Calibrators and Controls are ready-to-use, liquid formats that simplify calibration and quality control procedures. They can be fully customized to meet the unique needs of individual laboratories, taking into consideration specific testing requirements, LC/MS instrumentation and sample matricies. Custom profiles are easily edited or updated as needs change. Clinitox Calibrators and Controls come as ready-to-use single use ampoules with batch and lot certifications, ensuring they deliver the quality laboratories require.

Additionally, MedTest’s Certified Performance Guarantee Program for its Pointe Scientific branded line of clinical chemistry diagnostic reagents that was introduced at AACC 2019 is intended to provide an additional layer of assurance to customers that the company stands fully behind the quality and reliability of every Pointe Scientific branded clinical chemistry reagent it ships. MedTest will issue a free replacement to any customer who is not fully satisfied with the performance of their Pointe Scientific branded reagent.

“We are very proud of Pointe Scientific’s well-established reputation as a quality leader in diagnostic reagents, and that its products are manufactured here in the US,” said Wayne Brinster, Chief Executive Officer of MedTest Dx. “Pointe Scientific offers an extensive line of cost-effective clinical chemistry reagents, some of which it was the first to introduce to the market. The company’s long record of successful innovation and consistent high quality made the decision to implement the Certified Performance Guarantee Program an easy one. We view the Guarantee program as indicative of our ongoing commitment to serving as our customers’ partner of choice for clinical diagnostic testing technologies.”

Related Links:
MedTest Dx

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Coagulation Analyzer
CS-2400

Print article

Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.